Checkpoint Therapeutics to Present at the Jefferies 2017 Global Healthcare Conference
Jun 01, 2017 12:21 pm UTC| Business
NEW YORK, June 01, 2017 -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (OTCQX:CKPT), a Fortress Biotech (NASDAQ:FBIO) company, today announced that James F. Oliviero, President and Chief Executive Officer of...
Checkpoint Therapeutics to Present at the Jefferies 2017 Global Healthcare Conference
Jun 01, 2017 12:21 pm UTC| Business
NEW YORK, June 01, 2017 -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (OTCQX:CKPT), a Fortress Biotech (NASDAQ:FBIO) company, today announced that James F. Oliviero, President and Chief Executive Officer of...
Checkpoint Therapeutics to Present at the Jefferies 2017 Global Healthcare Conference
Jun 01, 2017 12:21 pm UTC| Business
NEW YORK, June 01, 2017 -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (OTCQX:CKPT), a Fortress Biotech (NASDAQ:FBIO) company, today announced that James F. Oliviero, President and Chief Executive Officer of...
Checkpoint Therapeutics to Present at the Jefferies 2017 Global Healthcare Conference
Jun 01, 2017 12:21 pm UTC| Business
NEW YORK, June 01, 2017 -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (OTCQX:CKPT), a Fortress Biotech (NASDAQ:FBIO) company, today announced that James F. Oliviero, President and Chief Executive Officer of...
Jun 01, 2017 12:21 pm UTC| Business
SAN DIEGO, June 01, 2017 -- Retrophin, Inc. (NASDAQ:RTRX) today announced that the United States Patent and Trademark Office (USPTO) and the European Patent Office (EPO) have each issued a patent covering the Company’s...
Checkpoint Therapeutics to Present at the Jefferies 2017 Global Healthcare Conference
Jun 01, 2017 12:21 pm UTC| Business
NEW YORK, June 01, 2017 -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (OTCQX:CKPT), a Fortress Biotech (NASDAQ:FBIO) company, today announced that James F. Oliviero, President and Chief Executive Officer of...
Checkpoint Therapeutics to Present at the Jefferies 2017 Global Healthcare Conference
Jun 01, 2017 12:21 pm UTC| Business
NEW YORK, June 01, 2017 -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (OTCQX:CKPT), a Fortress Biotech (NASDAQ:FBIO) company, today announced that James F. Oliviero, President and Chief Executive Officer of...
South Africa’s plan to move away from coal: 8 steps to make it succeed
Germany lowers voting age to 16 for the European elections
IceCube researchers detect a rare type of energetic neutrino sent from powerful astronomical objects